Lehtomäki, K.; Mustonen, H.; Kellokumpu-Lehtinen, P.-L.; Joensuu, H.; Hermunen, K.; Soveri, L.-M.; Boisen, M.K.; Dehlendorff, C.; Johansen, J.S.; Haglund, C.;
et al. Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers 2021, 13, 3892.
https://doi.org/10.3390/cancers13153892
AMA Style
Lehtomäki K, Mustonen H, Kellokumpu-Lehtinen P-L, Joensuu H, Hermunen K, Soveri L-M, Boisen MK, Dehlendorff C, Johansen JS, Haglund C,
et al. Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers. 2021; 13(15):3892.
https://doi.org/10.3390/cancers13153892
Chicago/Turabian Style
Lehtomäki, Kaisa, Harri Mustonen, Pirkko-Liisa Kellokumpu-Lehtinen, Heikki Joensuu, Kethe Hermunen, Leena-Maija Soveri, Mogens Karsbøl Boisen, Christian Dehlendorff, Julia Sidenius Johansen, Caj Haglund,
and et al. 2021. "Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer" Cancers 13, no. 15: 3892.
https://doi.org/10.3390/cancers13153892
APA Style
Lehtomäki, K., Mustonen, H., Kellokumpu-Lehtinen, P. -L., Joensuu, H., Hermunen, K., Soveri, L. -M., Boisen, M. K., Dehlendorff, C., Johansen, J. S., Haglund, C., & Osterlund, P.
(2021). Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers, 13(15), 3892.
https://doi.org/10.3390/cancers13153892
